Entero Healthcare (ENTERO) | Stock Overview & Key Data
Entero Healthcare Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹1,584.25 on November 4, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Entero Healthcare
ENTERO
|
54.69B Mid-cap | 0.29% | -5.86% | 12.11% | 12.06% | -0.64% | -4.75% | -1.12% | -1.12% | -1.12% | -1.12% | -1.12% |
|
NOVELIX
NOVELIX
|
1.16B Small-cap | 23.32% | 61.28% | 62.04% | 40.58% | 41.58% | 181.69% | 242.11% | 242.11% | 242.11% | 242.11% | 242.11% |
|
Royal Sense
ROYAL
|
924.51M Small-cap | 0.93% | -22.86% | -30.37% | -49.77% | -40.28% | -59.36% | -8.50% | -8.50% | -8.50% | -8.50% | -8.50% |
|
Amwill Health Care
AMWILL
|
669.92M Small-cap | 17.21% | 42.72% | 37.61% | 22.87% | -4.99% | -39.04% | -57.48% | -57.48% | -57.48% | -57.48% | -57.48% |
|
Trimurthi
TRIMURTHI
|
500.39M Small-cap | 23.32% | 61.28% | 62.04% | 40.58% | 41.58% | 169.35% | 768.13% | 774.86% | 1,174.19% | 381.71% | 381.71% |
|
Welcure Drugs
WELCURE
|
370.78M Small-cap | 0.00% | -10.34% | -3.70% | -45.83% | -38.10% | -75.00% | -25.00% | 17.39% | -77.50% | 50.00% | -30.77% |
Ownership & Short Interest
Calculate Your Entero Healthcare Investment Returns
Long-Term Investment Performance Analysis
Entero Healthcare stock price in Feb 2024 was ₹1,149.55, A ₹1,000.00 lump sum investment in Entero Healthcare made 2 years ago would be worth approximately ₹976.38 today, representing a negative return of -2.36%. This translates to an annualized return (CAGR) of -1.02%.
2 Years 4 Months Investment Scenario (Feb 2024 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ENTERO's 52-week high and low?
- In the last 52 weeks, Entero Healthcare reached a high of ₹1,390.00 (on May 25, 2026) and a low of ₹944.00 (on December 29, 2025).
- What is the market cap and P/E ratio for ENTERO?
- Curious about Entero Healthcare's size and valuation? Its market capitalization stands at 54.69B. When it comes to valuation, the P/E ratio (trailing twelve months) is 48.93, and the forward P/E (looking ahead) is 28.42.
- Does ENTERO pay dividends? If so, what's the yield?
- As for dividends, Entero Healthcare isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Entero Healthcare's main competitors or similar companies to consider before investing?
When looking at Entero Healthcare, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return NOVELIX
NOVELIX1.16B Healthcare Medical Distribution 181.69% 242.11% Royal Sense
ROYAL924.51M Healthcare Medical Distribution -59.36% -8.50% Amwill Health Care
AMWILL669.92M Healthcare Medical Distribution -39.04% -57.48% Trimurthi
TRIMURTHI500.39M Healthcare Medical Distribution 169.35% 768.13% Welcure Drugs
WELCURE370.78M Healthcare Medical Distribution -75.00% -25.00% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Entero Healthcare Solutions? (e.g., ROE, Debt/Equity)
- To get a sense of Entero Healthcare's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 5.36%, the Debt to Equity ratio from the most recent quarter is 24.63, and its Gross Profit Margin stands at 10.11%.
- What is the recent revenue and earnings growth for ENTERO?
- Looking at Entero Healthcare's growth, its revenue over the trailing twelve months (TTM) was INR60B. Compared to the same quarter last year (YoY), quarterly revenue grew by 25.60%, and quarterly earnings saw a YoY growth of 8.60%.
- How much of ENTERO stock is held by insiders and institutions?
- Wondering who owns Entero Healthcare stock? Company insiders (like executives and directors) hold about 65.97% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 12.55%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.